Anaesthesia and emesis. Clinical usefulness of metoclopramide
To the Editor: In the otherwise excellent review article "Anaesthesia and emesis, II" by Palazzo and Strunin, ~ the section devoted to metoclopramide is perhaps open to comment.
Reference is made to Davies and Howells' paper on the ability of metoclopramide to empty the stomach following injury, 2 which did not differentiate between liquid and solid gastric content. Hancock 3 showed no difference in gastric emptying times in normal subjects following a solid meal when they were given a placebo or metoclopramide. It is suggested that this is an important difference which should be taken into consideration by the anaesthetist who is faced with a patient with a full stomach. Liquid gastric content may be reduced but solid contents will not.
The authors claim that metoclopramide and domperidone have not proven to be effective in either prophylaxis or treatment of postoperative vomiting and refer, among others, to the work of Clark and Storrs 4 who in fact showed a significant reduction (p = 0.05) in postoperative vomiting after metoclopramide 20 mg.
A number of investigators have in fact found metoclopramide to be effective in the treatment and prophylaxis of postoperative vomiting, s-9
There are two properties of metoclopramide which the authors did not discuss. Firstly the more potent action in males compared to females. This was published as raw data by Kreel and Howells m but not referred to in the paper and also by Diamond and Keeri-Szanto ~ who showed a significant reduction in postoperative vomiting in males by prophylaxis with metoclopramide (p much less than 0.001) as compared to females in a similar surgical group (N. S.).
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Secondly, is the question of the freedom from side effects of this drug, which has best been illustrated by Gralla et al. ~2 who gave metoclopramide 120 mg at two hourly intervals over a ten hour period to patients undergoing Cisplatin chemotherapy. This resulted in a significant reduction in emesis when compared to placebo administration (p = 0.001) or to prochlorperazine administration (p = 0.005). The follow-up of 450 patients undergoing this regimen revealed acute dystonic reactions in only 3.1 per cent of the patients. ~3
It would appear that the recommendations of the authors of the review article to use another agent should a single dose of metoclopramide not prove effective is not borne out in the literature.
The Sloan-Kettering Experience suggests strongly that over a short period of time, high doses of metoclopramide are well tolerated, but the longterm effect of therapy may lead to extra pyramidal side effects. 
